The Healthy on MSN4d
12 Silent Signs of Skin Cancer You’re Probably Ignoring
The major types of skin cancer are basal cell carcinoma, squamous cell carcinoma, and melanoma. Basal cell carcinoma is the ...
WebMD1d
FDA Approves New Drug for Advanced Skin Cancer
The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
Cancer Therapy Advisor1d
Unloxcyt Approved for Advanced Cutaneous Squamous Cell Carcinoma
The US Food and Drug Administration (FDA) has approved Unloxcyt (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are ...
FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
Checkpoint Therapeutics' Unloxcyt wins FDA approval for advanced cSCC, marking the company's entry into the U.S. market, valued over $1 billion annually.
FDA Oks Checkpoint Therapeutics' UNLOXCYT For Advanced Cutaneous Squamous Cell Carcinoma treatment
The recommended commercial dosage of UNLOXCYT is 1,200 mg administered as an intravenous infusion over 60 minutes every three weeks. Cutaneous squamous cell carcinoma (cSCC) is the second most common ...
FiercePharma2d
Checkpoint Therapeutics takes on Merck's mighty Keytruda with FDA approval for Unloxcyt in skin cancer
The FDA has approved cosibelimab under the brand name Unloxcyt for the treatment of metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC that’s not curable by surgery or ...
Cure Today5d
FDA Approves Unloxcyt for Locally Advanced, Metastatic Skin Cancer Subset
Unloxcyt was approved by the FDA as a new treatment for patients with locally advanced or metastatic cutaneous squamous cell ...